Home › Research › How common it is
Dementia prevalence and risk factors in people with and without HIV in Malawi: A medical record review
Haeok Lee, Yohannie B. Mlombe, Yeunjoo E. Song, Hyun‐Sik Yang, Tiwonge Elisa Phiri, Joseph Maseke, Esther M. Bauleni, Gyungah Jun et al.. Alzheimer s & Dementia, 2025-03-01
Topic: Risk, prevention and care in population studies
Plain-language summary
The overall rate of dementia was higher in PLHIV than that in POHIV (22% vs 10%; p = 1.4e). Older age, unknown employment or unemployed, and depression were significant risk factors for dementia for PLHIV, while older age and depression were significant among POHIV. Our study confirmed the increased risk of dementia in PLHIV and provides valuable groundwork for future dementia studies to accurately examine the prevalence and risk factors of dementia in SSA, including Malawi. HIGHLIGHTS: Malawians, in SSA, face the double burden of HIV AD and related dementias. We conducted a retrospective medical record review to assess dementia prevalence and risk factors. Dementia prevalence was higher in PLHIV than in POHIV. Older age, unknown employment or unemployed, and depression were risk factors for dementia in PLHIV. Our findings, reflecting the current diagnosing and medical documenting practice in Malawi, provide valuable groundwork for future dementia research in Malawi.
What this study adds
Evidence grade: Low
In Malawi, dementia was more common in people living with HIV (22%) than in people without HIV (10%), with older age, unemployment and depression as risk factors. This record review provides groundwork for future dementia research in the region but does not test any treatment or prevention approach.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Lee, H., Mlombe, Y. B., Song, Y. E., Yang, H., Phiri, T. E., Maseke, J., et al. (2025). Dementia prevalence and risk factors in people with and without HIV in Malawi: A medical record review. Alzheimer s & Dementia. https://doi.org/10.1002/alz.70009
Vancouver
Lee H, Mlombe YB, Song YE, Yang H, Phiri TE, Maseke J, et al. Dementia prevalence and risk factors in people with and without HIV in Malawi: A medical record review. Alzheimer s & Dementia. 2025. doi:10.1002/alz.70009. PMID: 40042467.
BibTeX
@article{lee2025-40042467,
author = {Lee, Haeok and Mlombe, Yohannie B. and Song, Yeunjoo E. and Yang, Hyun‐Sik and Phiri, Tiwonge Elisa and Maseke, Joseph and Bauleni, Esther M. and Jun, Gyungah and others},
title = {{Dementia prevalence and risk factors in people with and without HIV in Malawi: A medical record review}},
journal = {Alzheimer s \& Dementia},
year = {2025},
doi = {10.1002/alz.70009},
pmid = {40042467},
url = {https://doi.org/10.1002/alz.70009}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- The overall rate of dementia was higher in PLHIV than that in POHIV (22% vs 10%; p = 1.4e).
- Older age, unknown employment or unemployed, and depression were significant risk factors for dementia for PLHIV, while older age and depression were significant among POHIV.
- Our study confirmed the increased risk of dementia in PLHIV and provides valuable groundwork for future dementia studies to accurately examine the prevalence and risk factors of dementia in SSA, including Malawi.
- HIGHLIGHTS: Malawians, in SSA, face the double burden of HIV AD and related dementias.
- We conducted a retrospective medical record review to assess dementia prevalence and risk factors.
Why it matters
In Malawi, dementia was more common in people living with HIV (22%) than in people without HIV (10%), with older age, unemployment and depression as risk factors. This record review provides groundwork for future dementia research in the region but does not test any treatment or prevention approach.
New to this subject? Start with our plain-English guide: Alzheimer's in numbers →
Study details
- Evidence strengthLow
How this study scored 43/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 2 / 7 | Cited 6 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 2.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 3 / 6 | Cited 3.8× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 1 / 4 | Cited 6 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Jonathan Ngoma: h-index 9 (OpenAlex, whole career) |
| Institution's track record | 3 / 3 | Harvard University: institution h-index 3,235 (OpenAlex) |
| Multicenter collaboration | 3 / 3 | OpenAlex lists 10 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40042467) |
| Free to read | 2 / 2 | Free to read |
| Total | 43 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in How common it is from nearby years
Also tagged “prevalence”
1,223 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,223 tagged studies.